Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2016
Pharma News, 2016
Oramed Announces Positive Top-Line Results from Phase IIb Oral Insulin Study
JERUSALEM, May 18, 2016 /PRNewswire/ — Oramed Pharmaceuticals Inc.
Bayer makes takeover offer for agriculture giant Monsanto
German drug and chemicals-maker Bayer has made a takeover bid for agricultural giant Monsanto in a deal that could create the world's biggest supplier of seeds and pesticides.
Atezolizumab (Tecentriq) Wins FDA Nod for Bladder Cancer
The FDA has given the green light to atezolizumab (Tecentriq, Genentech) for the treatment of patients with urothelial carcinoma, the most common type of bladder cancer.
Alvotech Announces Acquisition of Baliopharm
REYKJAVIK, Iceland (BUSINESS WIRE) -- Alvotech, a powerful player in the field of biopharmaceuticals, today announced that it has entered into a definitive agreement to acquire Baliopharm GmbH...
Aduro Biotech Announces Phase 2b ECLIPSE Trial Misses Primary Endpoint in Heavily Pretreated Metastatic Pancreatic Cancer
BERKELEY, Calif.
Senate approves $1.1bn for Zika fight but House alternative bill provides far less
The US Senate on Tuesday took a step toward funding the Obama administration’s efforts to combat the Zika virus, but paved the way for a showdown with the House of Representatives, where Republicans...
Iran to join insulin producers club in four years
TEHRAN — Iran will join the five countries producing insulin once the Pars Novo Nordisk pharmaceutical company comes on stream in the next four years, said the vice president and general manager of ...
Opdivo approved quickly for first hematological cancer
FDA granted accelerated approval to Opdivo nivolumab from Bristol-Myers Squibb Co.
Avanir Announces U.S. Launch And Availability Of ONZETRA Xsail
Avanir Pharmaceuticals, Inc.
Bengt Sjöberg donates SEK 2 billion to cancer research
Bengt Sjöberg, resident in Hong Kong but originally from Lysekil, Sweden, has founded the Sjöberg Foundation, to which he has donated SEK 2 billion.
Pfizer blocks its drugs from use in lethal injections
- Pfizer Inc has taken steps to ensure that none of its products are used in lethal injections, the largest U.
Mylan to Buy Renaissance Skin Drug Unit for About $1 Billion
Mylan NV agreed to buy skin drug assets from Renaissance Acquisition Holdings LLC for about $1 billion to complement its existing products.
34
35
36
37
38
39
40
41
42